Srilatha Tangada
4PUBLICATIONS
3CO-AUTHORS

Get your video featured.

Get your video featured.
Publications (4)
Sort by Publication Date:
|Apr 02, 2024
Immunogenicity profile of rurioctocog alfa pegol in previously treated patients with severe congenital hemophilia A.Frank M Horling, Birgit M Reipert, Peter Allacher
|Sep 01, 2020
Safety, Immunogenicity, and Hemostatic Efficacy of Nonacog Gamma in Patients With Severe or Moderately Severe Hemophilia B: A Continuation Study.Jerzy Windyga, Oleksandra Stasyshyn, Toshko Lissitchkov
|Aug 21, 2020
Phase 3 Clinical Trial: Perioperative Use of Nonacog Gamma, a Recombinant Factor IX, in Previously Treated Patients With Moderate/Severe Hemophilia B.Jerzy Windyga, Margarita Timofeeva, Oleksandra Stasyshyn
|Jul 30, 2019
Perioperative haemostasis with full-length, PEGylated, recombinant factor VIII with extended half-life (rurioctocog alfa pegol) in patients with haemophilia A: Final results of a multicentre, single-arm phase III trial.Ralph Gruppo, Maria-Fernanda López-Fernández, Tung T Wynn
Pageof 1

